European equities trading in the US as American depositary receipts were sharply higher late Monday morning, as the S&P Europe Select ADR Index rose 1.6% to 1,315.5.
From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and 3D printer company Materialise (MTLS), which climbed 20% and 6% respectively. They were followed by financial services company Banco Bilbao Vizcaya Argentaria (BBVA) and semiconductor company Sequans Communications (SQNS) that increased almost 5% and 3%, respectively.
The worst decliners in continental Europe were pharmaceutical company Novo Nordisk (NVO) and consumer goods giant Unilever (UL) losing roughly 2% each. They were followed by pharmaceutical company Ascendis Pharma (ASND) and Natuzzi (NTZ), which were down nearly 2% and 1%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics, (AKTX) and alcoholic beverage company Diageo (DEO), gaining 6% and 3%, respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and insurance firm Prudential (PUK), which were up 2.6% and 2.9%, respectively.
The worst decliners in the UK and Ireland were biopharmaceutical company TC Biopharm (TCBP) and communications company WPP (WPP), shedding 11% and 2% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL), which dropped 2.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。